| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/24/2005 | US20050065070 Peptide inhibitors of LFA-1/1Cam-1 interaction |
| 03/24/2005 | US20050065069 Use of hcg in controlled ovarian hyperstimulation |
| 03/24/2005 | US20050065068 Methods and compositions for reducing serum phosphate levels |
| 03/24/2005 | US20050065067 tetramer-free, substantially stroma-free, polymerized, pyridoxylated hemoglobin; free of leukocytes (white blood cells) and platelets |
| 03/24/2005 | US20050065066 Stabilised insulin compositions |
| 03/24/2005 | US20050065065 Modulation of the expression of estrogen receptors for the prevention or treatment of heart disease |
| 03/24/2005 | US20050065064 side-effect reduction; AIDS; reduced toxicity |
| 03/24/2005 | US20050064596 Buffer solution for electroporation and a method comprising the use of the same |
| 03/24/2005 | US20050064593 Expression vector comprising breast cancer gene (BCL-2) nucleotide sequences for use as tool in treatment, diagnosis and prevention of cell proliferative disorders |
| 03/24/2005 | US20050064572 Lipid kinase |
| 03/24/2005 | US20050064558 Chimeric polypeptide comprising functional differentially spliced interleukin receptor and b-cell differentiation factor for enhancing expression of interferon inducible protein (IP-10) and macrophage inflammarory proteins for use in treatment of viral diseases |
| 03/24/2005 | US20050064556 Transforming yeast cell with expression vector expressing gene coding tissue factor pathway inhibitor (TFPI) and tissue factor pathway inhibitor-2 (TFPI-2) for use as tool in treatment and prevention of thrombosis; bioreactors |
| 03/24/2005 | US20050064555 Ciliary neurotrophic factor variants |
| 03/24/2005 | US20050064554 Canine GHRH gene, polypeptides and methods of use |
| 03/24/2005 | US20050064553 Cryptosporidium parvum antigens, antibodies thereto and diagnostic and therapeutic compositions thereof |
| 03/24/2005 | US20050064546 Production of recombinant lactoferrin and lactoferrin polypeptides using cDNA sequences in various organisms |
| 03/24/2005 | US20050064543 Secreted proteins |
| 03/24/2005 | US20050064542 Nucleic acid expressed in the hypothalamus or muscle tissue in obese animals |
| 03/24/2005 | US20050064541 For immunoregulation and/or treatment of inflammation; muteins, |
| 03/24/2005 | US20050064539 Glycoprotein and process for producing the same |
| 03/24/2005 | US20050064527 Identifying modulator of activity of newly identified multiple antibiotic resistance (mar) locus regulated (NIMR) gene products; microbiocides; bactericides |
| 03/24/2005 | US20050064522 EG-VEGF nucleic acids and polypeptides and methods of use |
| 03/24/2005 | US20050064504 DNA encoding the prostate-specific membrane antigen-like gene and uses thereof |
| 03/24/2005 | US20050064501 Medicaments comprising inhibitors of the cell volume-regulated human kinase h-sgk |
| 03/24/2005 | US20050064499 Expression vector coding nucleotide sequences for use in identifying modulators for prevention and treatment of cell proliferative disorders |
| 03/24/2005 | US20050064496 Expression vector comprising therapeutic RNA sequences for use in treatment and prevention of infection, viral diseases and cell proliferative disorders; antisense agents; gene expression inhibition |
| 03/24/2005 | US20050064493 Antibodies specific for vascular endothelial growth factor-B and DNA coding therefor |
| 03/24/2005 | US20050064491 Transport protein for use as tool in identifying modulator for treatment of sleep, nervous suystem, anixety, eating, cardiovascular and pain disordere |
| 03/24/2005 | US20050064475 Using type II membrane glycoprotein (4F2hc) as tool in identifying modulator which inhibit transcription in tumor cells; gene expresion inhibition and antitumors agents |
| 03/24/2005 | US20050064458 Nucleotide sequences coding membrane protein for use in diagnosis, prevention and treatnment of cell proliferative, nervous system, metabolic and inflammatory disorders |
| 03/24/2005 | US20050064445 Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 03/24/2005 | US20050064443 Production of functional proteins: balance of shear stress and gravity |
| 03/24/2005 | US20050064440 Using single nucleotide polymorphism in contactin-2 (CNTN-2) and kinesin-7 (CENP-E) genes as diagnostic indicators of cell proliferative disorders; antitumor agents; ribozymes and tumor treatment; RNA interference |
| 03/24/2005 | US20050064439 Agents for pre-symptomatic detection and therapeutic targeting of alzheimer's disease and down syndrome in humans |
| 03/24/2005 | US20050064416 Methods for diagnosing and treating heart disease |
| 03/24/2005 | US20050064413 Oncogenic protein for use in diagnosis, prevention and treatment of cell proliferative disorders of nervous ystem |
| 03/24/2005 | US20050064411 Diagnostic probe for identifying ubiquitin ligase (NEDl-1) profile for use as diagnostic and prognostic indicator of cell proliferative disorders of nervous system |
| 03/24/2005 | US20050064409 Chp for use as marker for sepsis-type inflammatory diseases |
| 03/24/2005 | US20050064404 Regulation of human serotonin-like g protein-coupled receptor |
| 03/24/2005 | US20050064396 Cellular regulators of infectious agents and methods of use |
| 03/24/2005 | US20050064391 Lectin compositions and methods for modulating an immune response to an antigen |
| 03/24/2005 | US20050064390 Transgenic cell line expressing chemokine receptor for use as model in identifying modulators wich prevent/block viral infection; viricides |
| 03/24/2005 | US20050064032 Dosage form, device, and methods of treatment |
| 03/24/2005 | US20050064028 Pharmaceutical compositions containing plasma protein |
| 03/24/2005 | US20050064016 Methods for dietary management of cats to avoid hyperthyroidism |
| 03/24/2005 | US20050064015 administering lactoferrin and/or lactoferricin to a pregnant or lactating mother pet, to improve the health status of a newborn or young pet |
| 03/24/2005 | US20050063997 Mixture of macrolactone antibodies and mycophenolic acid ; antiinflammatory agents; antiproliferative agents; topical drug |
| 03/24/2005 | US20050063996 Ocular solutions |
| 03/24/2005 | US20050063993 For treatment of cancer/tumors/fungal/viral infections; tumor associated antigens; genetic engineering |
| 03/24/2005 | US20050063987 Proteins, in particular membrane proteins, of Helicobacter pylori, their preparation and use |
| 03/24/2005 | US20050063986 Process for the preparation of non-toxic anthrax vaccine |
| 03/24/2005 | US20050063985 Method and compositions for immunization with the pseudomonas v antigen |
| 03/24/2005 | US20050063983 Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions |
| 03/24/2005 | US20050063978 With a carrier peptide adjuvant that is able to strongly enhance the immune response to a specific co-administered antigen |
| 03/24/2005 | US20050063975 Serpentine transmembrane epithelial antigens of the prostate; polynucleotides, recombinant expression vectors, and host cells; anticarcinogenic agents |
| 03/24/2005 | US20050063974 Detecting expression of a tyrosine threonine kinase-encoding polynucleotide in order to assess prognosis of colon or breast cancer |
| 03/24/2005 | US20050063973 An antibody that binds specifically to TMF/ARA160 protein; receptor binding assay; gene expression inhibition of Fer using RNA interference; drug screening; prostate cancer |
| 03/24/2005 | US20050063972 via ion exchange chromatography via changing the conductivity and/or pH of buffers; humanized antibodies and acidic variants |
| 03/24/2005 | US20050063971 Monoclonal or humanized antibodies that immunospecifically bind to FGF-CX or any derivative, variant, mutant, polypeptide fragment, polynucleotide or antibody |
| 03/24/2005 | US20050063969 Assay |
| 03/24/2005 | US20050063965 Prevention and treatment of oxidative stress disorders by glutathione and phase II detoxification enzymes |
| 03/24/2005 | US20050063958 Ex vivo gene therapy for HIV; formulation of CD34+ hematopoietic cells transduced with a viral construct which expresses an anti-HIV agent such as a ribozyme |
| 03/24/2005 | US20050063951 Function of a haptoglobin-haemoglobin receptor and the uses thereof |
| 03/24/2005 | US20050063950 Cell-targeting ligand (e.g. transferrin) noncovalently bound directly to a virus; less inactivation of ligand than with conjugation; tissue targeted therapy; sensitizing cancer cells prior to chemotherapy or radiotherapy |
| 03/24/2005 | US20050063949 Method of treating hepatitis virus infection with a multiphasic interferon delivery profile |
| 03/24/2005 | US20050063948 Methods for targeting interleukin-12 to malignant endothelium |
| 03/24/2005 | US20050063947 Method for treating cancer in humans |
| 03/24/2005 | US20050063946 Human pluripotent hematopoietic colony stimulating factor, method of production and use |
| 03/24/2005 | US20050063945 Fusion protein of two different cytokines, one capable of enhancing a nonspecific immune response, and the other capable of enhancing a specific immunity; fusion protein of Interleukin-2 (Il-2) and IL-7 for example; use in immunotherapy such as cancer vaccine |
| 03/24/2005 | US20050063944 Method of inducing maturation of dendritic cells and uses therefor |
| 03/24/2005 | US20050063943 Conjugated of hydroxyalkyl starch and an active agent |
| 03/24/2005 | US20050063937 Multiple-arm peptide compounds, methods of manufacture and use in therapy |
| 03/24/2005 | US20050063936 Branched polyalkylene glycols |
| 03/24/2005 | US20050063932 Antiwrinkling and exfoliating complex; improved elasticity and firmness |
| 03/24/2005 | US20050063931 Via peptide which is a NK1-receptor (neurokinin-1) antagonist |
| 03/24/2005 | US20050063922 Dental restorative materials |
| 03/24/2005 | US20050063912 Process for manufacturing bulk solutions and a lyophilized pure alpha-aztreonam lysinate |
| 03/24/2005 | DE10339180A1 Kollagenhydrolysat Collagen |
| 03/24/2005 | DE10338733A1 Fusionspolypeptide und deren Verwendung für die antivaskuläre Tumortherapie Fusion polypeptides and their use for the anti-vascular cancer therapy |
| 03/24/2005 | DE102004028302A1 Stimulierung der Synthese und der Aktivität einer Isoform der Lysyloxidase-ähnlichen LOXL zum Stimulieren der Bildung von elastischen Fasern Stimulation of the synthesis and the activity of one isoform of the lysyl oxidase-like LOXL for stimulating the formation of elastic fibers |
| 03/24/2005 | DE102004028300A1 Stimulierung der Aktivität eines Isoform des Lysyloxidase zum Bekämpfen von einigen Pathologien, die durch eine unvollständige, fehlende oder desorganisierte Elastogenese verursacht sind Stimulation of the activity of an isoform of the lysyl oxidase for controlling some pathologies which are caused by an incomplete, missing or disorganized elastogenesis |
| 03/24/2005 | CA2788502A1 Non-peptide agonists and antagonists of adrenomedullin and gastric releasing peptide |
| 03/24/2005 | CA2578375A1 Vaccine immunotherapy for immune suppressed patients |
| 03/24/2005 | CA2542303A1 A composition and method of treatment for urogenital conditions |
| 03/24/2005 | CA2539380A1 Method for producing insulin from a natural source and insulin |
| 03/24/2005 | CA2539300A1 Inhibitors of pace4 for the treatment of arthritis |
| 03/24/2005 | CA2539132A1 Methods for identifying modulators of protein kinase c-epsilon (pkc.epsilon.) and method of treatment of aberrant glucose metabolism associated therewith |
| 03/24/2005 | CA2539033A1 Treatment of disease or injury of the nervous system with fty720 |
| 03/24/2005 | CA2539000A1 Combination of a histone deacetylase inhibitor with a death receptor ligand |
| 03/24/2005 | CA2538883A1 Antisense oligonucleotides for prevention of metastasis formation of cancer cells |
| 03/24/2005 | CA2538843A1 Animal model for protease activity and liver damage |
| 03/24/2005 | CA2538495A1 The use of eukaryotic genes affecting chromatin separation for diagnosis and treatment of proliferative diseases |
| 03/24/2005 | CA2538461A1 The use of eukaryotic genes affecting spindle formation or microtubule function during cell division for diagnosis and treatment of proliferative diseases |
| 03/24/2005 | CA2538442A1 Eukaryotic genes for modulating cell cycle progression |
| 03/24/2005 | CA2538429A1 Antibacterial drug for propionibacterium acnes |
| 03/24/2005 | CA2538422A1 Method to enhance hematopoiesis |
| 03/24/2005 | CA2538075A1 Base-substituted benzylamine analogs for use as coagulation factor xa inhibitors, the production and use thereof |
| 03/24/2005 | CA2538069A1 Effectors of innate immunity determination |
| 03/24/2005 | CA2537735A1 Injectable calcium phosphate solid rods and pastes for delivery of osteogenic proteins |
| 03/24/2005 | CA2537696A1 Plasminogen activators having a reduced capacity to bind lysine |